Publications by authors named "Michail Botis"

Claim this Profile
V
Valvular Heart Disease in Non-Valvular Heart Failure Continuum: The Role of Cardiopulmonary Exercise Testing.
Kiriaki Mavromoustakou, Michail Botis, Panagiotis Iliakis, Ioannis Leontsinis, Panagiotis Xydis

Biomedicines· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reappraising Use of Flecainide for Atrial Fibrillation and Ventricular Arrhythmias in Structural Heart Disease Patients.
Dimitrios Tsiachris, Sotirios C Kotoulas, Ioannis Doundoulakis, Christos-Konstantinos Antoniou, Michail Botis

Medicina (Kaunas)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sepsis-Induced Cardiomyopathy and Cardiac Arrhythmias: Pathophysiology and Implications for Novel Therapeutic Approaches.
Konstantinos Pamporis, Paschalis Karakasis, Antonia Pantelidaki, Panagiotis Antonios Goutis, Konstantinos Grigoriou, Michail Botis

Biomedicines· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atrial fibrillation burden: Stepping beyond the categorical characterization.
Ioannis Doundoulakis, Sotirios Nedios, Stefanos Zafeiropoulos, Marco Vitolo, Domenico Giovanni Della Rocca, Michail Botis

Heart Rhythm· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Flecainide in Idiopathic Premature Ventricular Contractions and the Induced Cardiomyopathy-UNIFLECA: A Single Arm, Non-Randomized Trial: Review of the Literature and Initial Results.
Sotirios Kotoulas, Dimitrios Tsiachris, Michail Botis, Athanasios Kordalis, Dimitrios Varvarousis

J Pers Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total Atrial Conduction Time as a Predictor of Atrial Fibrillation Recurrence: A Systematic Review and Meta-Analysis.
Sotirios Chiotis, Ioannis Doundoulakis, Eirini Pagkalidou, Christos Piperis, Stefanos Zafeiropoulos, Michail Botis

Cardiol Rev· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic inertia in rhythm control strategies in hospitalized patients with fibrillation: Insights from Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study.
Panayotis K Vlachakis, Dimitris Tsiachris, Ioannis Doundoulakis, Panagiotis Tsioufis, Athanasios Kordalis, Michail Botis

J Cardiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulation Status and Left Atrial Appendage Occlusion Indications in Hospitalized Cardiology Patients with Atrial Fibrillation: A Hellenic Cardiorenal Morbidity Snapshot (HECMOS) Sub-Study.
Dimitris Tsiachris, Panteleimon E Papakonstantinou, Ioannis Doundoulakis, Panagiotis Tsioufis, Michail Botis

Medicina (Kaunas)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Electrocardiographic Characteristics, Identification, and Management of Frequent Premature Ventricular Contractions.
Dimitris Tsiachris, Michail Botis, Ioannis Doundoulakis, Lamprini Iro Bartsioka, Panagiotis Tsioufis

Diagnostics (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in patients with atrial fibrillation treated with digoxin, according to the presence of heart failure: Insights from the MISOAC-AF trial.
Michail Botis, Anastasios Kartas, Athanasios Samaras, Evangelos Akrivos, Elena Vrana

Hellenic J Cardiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum.
Dimitrios V Moysidis, Anastasios Kartas, Athanasios Samaras, Andreas S Papazoglou, Evangelos Akrivos, Michail Botis

Hellenic J Cardiol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal function and mortality in patients with atrial fibrillation.
Evangelos Liampas, Anastasios Kartas, Athanasios Samaras, Andreas S Papazoglou, Dimitrios V Moysidis, Michail Botis

J Cardiovasc Med (Hagerstown)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Education level predicts mortality and morbidity in hospitalised patients with atrial fibrillation.
Vasiliki Patsiou, Dimitrios V Moysidis, Anastasios Kartas, Athanasios Samaras, Andreas S Papazoglou, Michail Botis

Hellenic J Cardiol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral anticoagulation patterns and prognosis in octogenarian patients with atrial fibrillation.
Anastasios Papanastasiou, Anastasios Kartas, Athanasios Samaras, Eleni Vrana, Andreas Papazoglou, Michail Botis

J Thromb Thrombolysis· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of Atrial Fibrillation Patterns With Mortality and Cardiovascular Events: Implications of the MISOAC-AF Trial.
Amalia Baroutidou, Anastasios Kartas, Athanasios Samaras, Andreas S Papazoglou, Eleni Vrana, Michail Botis

J Cardiovasc Pharmacol Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
Τhe association of heart failure across left ventricular ejection fraction with mortality in atrial fibrillation.
Anastasios Kartas, Athanasios Samaras, Evangelos Akrivos, Eleni Vrana, Andreas S Papazoglou, Michail Botis

ESC Heart Fail· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of diabetes mellitus in patients with atrial fibrillation.
Andreas S Papazoglou, Anastasios Kartas, Athanasios Samaras, Ioannis Vouloagkas, Eleni Vrana, Michail Botis

Cardiovasc Diabetol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis